Korro Bio, Inc. (KRRO) News
Track canonical SquawkNews coverage tagged to KRRO, Korro Bio, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 8 indexed stories across 6 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) NASDAQ:KRRO, a biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA®) platform to develop a new class of
NEWS | Sep 11, 2026, 08:11 PM UTC
L
KRRO - Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
KRRO - Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
NEWS | Sep 11, 2026, 08:05 PM UTC
L
Korro to Participate in Upcoming Investor Conferences
Korro to Participate in Upcoming Investor Conferences
EQUITY | Aug 27, 2026, 11:07 AM UTC
L
KRRO - Korro to Participate in Upcoming Investor Conferences
KRRO - Korro to Participate in Upcoming Investor Conferences
EQUITY | Aug 27, 2026, 11:00 AM UTC
L
Korro Bio reports inducement grant under Nasdaq Rule 5635(c)(4)
Korro Bio reports an inducement grant under Nasdaq Listing Rule 5635(c)(4); no grant size, recipient details or catalyst was supplied.
REGULATION | Aug 14, 2026, 08:05 PM UTC
L
Korro Bio Form 4: Lynx1 Capital Management LPP buys 6,684 shares
Korro Bio, Inc. files a Form 4 showing 10% owner Lynx1 Capital Management LPP purchasing 6,684 shares at $11.791 per share for a reported $78,809 total.
REGULATION | Aug 13, 2026, 02:06 PM UTC
L
KRRO - Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update
KRRO - Korro Reports Second Quarter 2026 Financial Results and Provides Corporate Update
EARNINGS | Aug 06, 2026, 11:01 AM UTC
L
Korro Bio Insider Sold Shares Worth $1,542,970, According to a Recent SEC Filing
() -- Jean Francois Formela, Director, on July 02, 2026, sold 110,023 shares in Korro Bio (KRRO) for $1,542,970. Following the Form 4 filing with the SEC, Formela has control over a total of 852,861 common shares of the
REGULATION | Jul 08, 2026, 08:06 AM UTC